Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs

Blood

Volumn 119, Issue 7, 2012, Pages 1623-1633

  Van Den Bossche, Jan ^a   Malissen, Bernard ^b,c,d   Mantovani, Alberto ^e,f   De Baetselier, Patrick ^a   Van Ginderachter, Jo A ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c INSERM   (France)

^d CNRS   (France)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA7 INTEGRIN; CATENIN; CD103 ANTIGEN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; NATURAL KILLER CELL LECTIN LIKE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UVOMORULIN; WNT PROTEIN;

CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL ADHESION; CELL FUSION; CELL HETEROGENEITY; CELL LINEAGE; CELL MATURATION; DENDRITIC CELL; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INTRACELLULAR SIGNALING; LANGERHANS CELL; MACROPHAGE; MONOCYTE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84857466255     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-384289     Document Type: Review

References (110)

1. Halbleib JM, Nelson WJ. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 2006;20(23):3199-3214. (Pubitemid 44904842)
2. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65(23): 3756-3788.
3. Tunggal JA, Helfrich I, Schmitz A, et al. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J. 2005;24(6): 1146-1156. (Pubitemid 40516598)
4. Ireton RC, Davis MA, van Hengel J, et al. A novel role for p120 catenin in E-cadherin function. J Cell Biol. 2002;159(3):465-476. (Pubitemid 35332833)
5. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin filament assembly. Cell. 2005;123(5):903-915. (Pubitemid 41721035)
6. Abe K, Takeishi M. EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc Natl Acad Sci U S A. 2008;105(1):13-19.
7. Nawijn MC, Hackett TL, Postma DS, van Oosterhout AJM, Heijink IH. E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends Immunol. 2011;32(6):248-255.
8. Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med. 2006;203(2):289-295. (Pubitemid 43290837)
9. Li Y, Hofmann M, Wang Q, et al. Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing-self recognition. Immunity. 2009;31(1): 35-46.
10. Nakamura S, Kuroki K, Ohki I, et al. Molecular basis for E-cadherin recognition by killer cell lectin- like receptor G1 (KLRG1). J Biol Chem. 2009; 284(40):27327-27335.
11. Tessmer MS, Fugere C, Stevenaert F, et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol. 2007;19(4):391- 400.
12. Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, Brossay L. Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J Immunol. 2002;168(6):2585-2589. (Pubitemid 34211630)
13. Huntington ND, Tabarias H, Fairfax K, et al. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol. 2007;178:4764-4770. (Pubitemid 46595257)
14. Schwartzkopff S, Gründemann C, Schweier O, et al. Tumor-associated E-cadherin mutations affect binding of to the killer cell lectin-like receptor G1 in humans. J Immunol. 2007;179(2):1022- 1029.
15. Robbins SH, Terrizzi SC, Sydora BC, Mikayama T, Brossay L. Differential regulation of killer cell lectin-like receptor G1 expression on T cells. J Immunol. 2003;170(12):5876-5885. (Pubitemid 36682566)
16. Beyersdorf NB, Ding X, Karp K, Hanke T. Expression of inhibitory "killer cell lectin-like receptor G1"identifies unique subpopulations of effector and memory CD8 T cells. Eur J Immunol. 2001; 31(12):3443-3452. (Pubitemid 34030956)
17. Beyersdorf N, Ding X, Tietze JK, Hanke T. Characterization of mouse CD4 T-cell subsets defined by expression of KLRG1. Eur J Immunol. 2007; 37(12):3445-3454.
18. Rosshart S, Hofmann M, Schweier O, et al. Interaction of KLRG1 with E-cadherin: new functional and structural insights. Eur J Immunol. 2008; 38(12):3354-3364.
19. Henson SM, Franzese O, Macauley R, et al. KLRG1 signaling induces defective Akt (Ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood. 2009; 113(26):6619-6628.
20. Streeck H, Kwon DS, Pyo A, et al. Epithelial adhesion molecules can inhibit HIV-1-specific CD8+ T-cell functions. Blood. 2011;117(19): 5112-5122.
21. Shiraishi K, Tsuzaka K, Yoshimoto K, et al. Critical role of the fifth domain of E-cadherin for heterophilic adhesion with alpha(E)beta(7) but not for homophilic adhesion. J Immunol. 2005;175(2): 1014-1021. (Pubitemid 41094986)
22. Cepek KL, Shaw SK, Parker CM, et al. Adhesion between epithelial cells and T-lymphocytes mediated by E-cadherin and the alpha(E)beta(7) integrin. Nature. 1994;372(6502):190-193.
23. Schön MP, Arya A, Murphy EA, et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha(E) (CD103)-deficient mice. J Immunol. 1999;162(11):6641-6649. (Pubitemid 29309388)
24. Schlickum S, Sennefelder H, Friedrich M, et al. Integrin alpha E(CD103)beta 7 influences cellular shape and motility in a ligand-dependent fashion. Blood. 2008;112(3):619-625.
25. Uchida Y, Kawai K, Ibusuki A, Kanekura T. Role for E-cadherin as an inhibitory receptor on epidermal gammadelta T cells. J Immunol. 2011; 186(12):6945-6954.
26. Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol. 2005;174(9):5444-5455. (Pubitemid 40593184)
27. El-Asady R, Yuan R, Liu K, et al. TGFβ-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med. 2005; 201(10):1647-1657. (Pubitemid 40721008)
28. Le Floc'h A, Jalil A, Franciszkiewicz K, Validire P, Vergnon I, Mami-Chouaib F. Minimal engagement of CD103 on cytotoxic T lymphocytes with an E-cadherin- Fc molecule triggers lytic granule polarization via a phospholipase Cgamma-dependent pathway. Cancer Res. 2011;71(2):328-338.
29. del Rio ML, Bernhardt G, Rodriguez-Barbosa JI, Förster R. Development and functional specialization of CD103+ dendritic cells. Immunol Rev. 2010;234(1):268-281.
30. Staal FJ, Luis TC, Tiemessen MM. WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol. 2008;8(8):581-593.
31. Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001;153(5):1049-1059. (Pubitemid 34289243)
32. Torres VA, Tapia JC, Rodriguez DA, et al. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced β-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol. 2007;27(21):7703-7717. (Pubitemid 350033675)
33. Maher MT, Flozak AS, Stocker AM, Chenn A, Gottardi CJ. Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol. 2009;186(2):219-228.
34. Casagolda D, del Valle-Perez B, Valls G, et al. A p120-catenin-CK1epsilon complex regulates Wnt signaling. J Cell Sci. 2010;123(15):2621-2631.
35. Schaale K, Neumann J, Schneider D, Ehlers S, Reiling N. Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur J Cell Biol. 2011; 90(6):553-559.
36. Jiang A, Bloom O, Ono S, et al. Disruption of E-cadherin- mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity. 2007;27(4):610-624. (Pubitemid 47615505)
37. Manicassamy S, Reizis B, Ravindran R, et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science. 2010;329(5993):849-853.
38. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010;11(5):329-341.
39. McLachlan RW, Kraemer A, Helwani FM, Kovacs EM, Yap AS. E-cadherin adhesion activates c-Src signaling at cell-cell contacts. Mol Biol Cell. 2007; 18(8):3214-3223. (Pubitemid 47235324)
40. Pece S, Chiariello M, Murga C, Gutkind JS. Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions: evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem. 1999;274(27):19347-19351.
41. Xie Z, Bikle DD. The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium- induced phospholipase C-gamma1 activation and human keratinocyte differentiation. J Biol Chem. 2007;282(12):8695-8703. (Pubitemid 47093520)
42. De Santis G, Miotti S, Mazzi M, Canevari S, Tomassetti A. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene. 2009;28(9):1206- 1217.
43. Laprise P, Langlois M-J, Boucher M-J, Jobin C, Rivard N. Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. J Cell Physiol. 2004;199(1):32-39. (Pubitemid 38197511)
44. Georgopoulos NT, Kirkwood LA, Walker DC, Southgate J. Differential regulation of growth-promoting signalling pathways by E-cadherin. PLoS One. 2010;5(10):e13621.
45. Fournier MV, Fata JE, Martin KJ, Yaswen P, Bissell MJ. Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells. Cancer Res. 2009;69(10):4545-4552.
46. Lau MT, Klausen C, Leung PCK. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression. Oncogene. 2011;30(24):2753-2766.
47. Luyendyk JP, Schabbauer GA, Tencati M, Holscher T, Pawlinski R, Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide- induced cytokine and tissue factor gene expression in monocytes/macrophages. J Immunol. 2008;180(6):4218-4226.
48. Fukao T, Tanabe M, Terauchi Y, et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol. 2002;3(9):875- 881.
49. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol. 2008;9(9):690-701.
50. Nakagawa M, Fukata M, Yamaga M, Itoh N, Kaibuchi K. Recruitment and activation of Rac1 by the formation of E-cadherin-mediated cell-cell adhesion sites. J Cell Sci. 2001;114(10):1829- 1838.
51. Fukuyama T, Ogita H, Kawakatsu T, Inagaki M, Takai Y. Activation of Rac by cadherin through the c-Src-Rap1-phosphatidylinositol 3-kinase-Vav2 pathway. Oncogene. 2006;25(1):8-19. (Pubitemid 43049999)
52. Goodwin M, Kovacs EM, Thoreson MA, Reynolds AB, Yap AS. Minimal mutation of the cytoplasmic tail inhibits the ability of E-cadherin to activate Rac but not phosphatidylinositol 3-kinase. J Biol Chem. 2003;278(23):20533-20539.
53. Anastasiadis PZ, Moon SY, Thoreson MA, et al. Inhibition of RhoA by p120 catenin. Nat Cell Biol. 2000;2(9):637-644.
54. Soto E, Yanagisawa M, Marlow LA, Copland JA, Perez EA, Anastasiadis PZ. p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression. J Cell Biol. 2008; 183(4):737-749.
55. Asnaghi L, Vass WC, Quadri R, et al. E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene. 2010;29(19):2760-2771.
56. Cowell CF, Yan IK, Eiseler T, Leightner AC, Döppler H, Storz P. Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1. J Cell Biochem. 2009; 106(4):714-728.
57. Ridley AJ. Regulation of macrophage adhesion and migration by Rho GTP-binding proteins. J Microsc. 2008;231(3):518-523.
58. Tanizaki H, Egawa G, Inaba K, et al. Rho-mDia1 pathway is required for adhesion, migration and T-cell stimulation in dendritic cells. Blood. 2010; 116(26):5875-5884.
59. Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009;1(5):a000141.
60. Kuphal S, Poser I, Jobin C, Hellerbrand C, Bosserhoff AK. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene. 2004;23(52):8509-8519. (Pubitemid 39540801)
61. Solanas G, Porta-de-la-Riva M, Agusti C, et al. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci. 2008;121(13):2224-2234.
62. Perez-Moreno M, Davis MA, Wong E, Pasolli HA, Reynolds AB, Fuchs E. p120-catenin mediates inflammatory responses in the skin. Cell. 2006; 124(3):631-644. (Pubitemid 43199446)
63. Stairs DB, Bayne LJ, Rhoades B, et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell. 2011;19(4):470-483.
64. Henri S, Guilliams M, Poulin LF, et al. Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol. 2010;88(4):366-375.
65. Guilliams M, Henri S, Tamoutounour S, et al. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol. 2010;40(8):2089-2094.
66. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A. 2002;99(1):351-358. (Pubitemid 34060366)
67. Probst HC, Lagnel J, Kollias G, van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity. 2003;18(5):713-720. (Pubitemid 36588587)
68. Spörri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol. 2005; 6(2):163-170. (Pubitemid 40268197)
69. Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol. 2010;185(6):3248-3255.
70. Villablanca EJ, Mora JR. A two-step model for Langerhans cell migration to skin-draining LN. Eur J Immunol. 2008;38(11):2975-2980.
71. Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22(5):643-654. (Pubitemid 40719199)
72. Riedl E, Stöckl J, Majdic O, Scheinecker C, Knapp W, Strobl H. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood. 2000; 96(13):4276-4284.
73. Kautz-Neu K, Noordegraaf M, Dinges S, et al. Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med. 2011; 208(5):885-891.
74. Wilson NS, Young LJ, Kupresanin F, et al. Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling. Immunol Cell Biol. 2008;86(2):200-205. (Pubitemid 351301757)
75. Vander Lugt B, Beck ZT, Fuhlbrigge RC, Hacohen N, Campbell JJ, Boes M. TGF-beta suppresses beta-catenin-dependent tolerogenic activation program in dendritic cells. PLoS One. 2011;6(5): e20099.
76. Murphy KM. Comment on "Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine." Science. 2011; 333(6041):405.
77. Borkowski TA, Van Dyke BJ, Schwarzenberger K, McFarland VW, Farr AG, Udey MC. Expression of E-cadherin by murine dendritic cells: E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur J Immunol. 1994;24(11):2767-2774. (Pubitemid 24342195)
78. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med. 2009;206(13):2937-2946.
79. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001;2(4):361-367. (Pubitemid 33706348)
80. Sung SS, Fu SM, Rose CE Jr, Gaskin F, Ju ST, Beaty SR. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol. 2006;176(4):2161- 2172. (Pubitemid 43201663)
81. Siddiqui KR, Laffont S, Powrie F. E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity. 2010;32(4):557-567.
82. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009;9(4): 259-270.
83. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010; 327(5966):656-661.
84. Mukhopadhyay S, Plüddemann A, Gordon S. Macrophage pattern recognition receptors in immunity, homeostasis and self tolerance. Adv Exp Med Biol. 2009;653:1-14.
85. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958-969.
86. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and function. Immunity. 2010;32(5):593-604.
87. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889- 896.
88. Rehli M, Sulzbacher S, Pape S, et al. Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J Immunol. 2005; 174(11):7111-7122. (Pubitemid 40705677)
89. Ghassabeh GH, De Baetselier P, Brys L, et al. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood. 2006;108(2):575-583. (Pubitemid 44061358)
90. Van den Bossche J, Bogaert P, van Hengel J, et al. Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/ catenin complexes. Blood. 2009;114(21):4664- 4674.
91. Movahedi K, Laoui D, Gysemans C, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010; 70(14):5728-5739.
92. Laoui D, Van Overmeire E, Movahedi K, et al. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology. 2011; 216(11):1192-1202.
93. Schietke R, Warnecke C, Wacker I, et al. The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem. 2010;285(9):6658- 6669.
94. Helming L, Tomasello E, Kyriakides TR, et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal. 2008;1(43):ra11.
95. Skokos EA, Charokopos A, Khan K, Wanjala J, Kyriakides TR. Lack of TNF-alpha-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages. Am J Pathol. 2011; 178(5):2311-2321.
96. Helming L, Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol. 2009; 19(10):514-522.
97. Sica A, Mantovani A. Macrophage fusion cuisine. Blood. 2009;114(21):4609-4610.
98. McNally AK, Anderson JM. Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells. Exp Mol Pathol. 2011; 91(3):673-681.
99. Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J Leukoc Biol. 2007;82(6): 1542-1553. (Pubitemid 350276966)
100. Suparak S, Muangsombut V, Riyapa D, et al. Burkholderia pseudomallei-induced cell fusion in U937 macrophages can be inhibited by monoclonal antibodies against host cell surface molecules. Microbes Infect. 2011;13(12):1006-1011.
101. Paloneva J, Mandelin J, Kiialainen A, et al. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med. 2003;198(4):669-675. (Pubitemid 37045349)
102. Yagi M, Miyamoto T, Sawatani Y, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med. 2005;202(3):345-351. (Pubitemid 41126951)
103. Mbalaviele G, Chen H, Boyce BF, Mundy GR, Yoneda T. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest. 1995; 95(6):2757-2765.
104. Banh C, Fugere C, Brossay L. Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling. Blood. 2009;114(26):5299-5306.
105. Takahashi-Yanaga F, Kahn M. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res. 2010;16(12):3153-3162.
106. INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol. 2006;76:23-32.
107. Geissmann F, Emile JF, Andry P, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol. 1997;181(3):301-304. (Pubitemid 27156843)
108. Meijer L, Flajolet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci. 2004;25(9):471-480. (Pubitemid 39149703)
109. Pawelek JM. Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol. 2005; 6(12):988-993. (Pubitemid 41685232)
110. Dupasquier M, Stoitzner P, Wan H, et al. The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling. J Leukoc Biol. 2006;80(4):838-849. (Pubitemid 44835902)